Shares of Biofrontera (BFRI+147.1%) have skyrocketed today after Roth Capital initiated the stock with a buy rating and a $20 price target (~660% upside). Analyst Jonathan Aschoff says his rating and ...
网页链接Shares of Biofrontera (BFRI+147.1%) have skyrocketed today after Roth Capital initiated the stock with a buy rating and a $20 price target (~660% upside). Analyst Jonathan Aschoff says his rating and ...
网页链接
精彩评论